[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis 2015-2019 and Forecast 2020-2025

January 2020 | 94 pages | ID: G102C9CB0B1BEN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Exenatied
  • Liraglutide
  • Lixisenatide
  • Albiglutide
  • Dulaglutide
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Novo Nordisk
  • AstraZeneca
  • Eli Lily
  • GSK
  • Sanofi
  • Bristol-Myers Squibb
  • Amylin
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Hospital
  • Pharmacy
  • Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.2.2 Downstream
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET BY TYPE

3.1 By Type
  3.1.1 Exenatied
Table Major Company List of Exenatied
  3.1.2 Liraglutide
Table Major Company List of Liraglutide
  3.1.3 Lixisenatide
Table Major Company List of Lixisenatide
  3.1.4 Albiglutide
Table Major Company List of Albiglutide
  3.1.5 Dulaglutide
Table Major Company List of Dulaglutide
3.2 Market Size
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Type, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2015-2019, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Type, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Novo Nordisk (Company Profile, Sales Data etc.)
  4.1.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
  4.1.2 Novo Nordisk Products & Services
  4.1.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
  4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
  4.2.2 AstraZeneca Products & Services
  4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Eli Lily (Company Profile, Sales Data etc.)
  4.3.1 Eli Lily Profile
Table Eli Lily Overview List
  4.3.2 Eli Lily Products & Services
  4.3.3 Eli Lily Business Operation Conditions
Table Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 GSK (Company Profile, Sales Data etc.)
  4.4.1 GSK Profile
Table GSK Overview List
  4.4.2 GSK Products & Services
  4.4.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Sanofi (Company Profile, Sales Data etc.)
  4.5.1 Sanofi Profile
Table Sanofi Overview List
  4.5.2 Sanofi Products & Services
  4.5.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
  4.6.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
  4.6.2 Bristol-Myers Squibb Products & Services
  4.6.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amylin (Company Profile, Sales Data etc.)
  4.7.1 Amylin Profile
Table Amylin Overview List
  4.7.2 Amylin Products & Services
  4.7.3 Amylin Business Operation Conditions
Table Business Operation of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue 2015-2019, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share in 2019, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume 2015-2019, by Company, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Market Concentration, in 2019
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists MMarket Concentration, in 2019
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospital
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2015-2019, in Volume
  6.1.2 Demand in Pharmacy
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2015-2019, in Volume
  6.1.3 Demand in Others
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2025, by Application, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2020-2025, by Application, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2025, by Application, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2025, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2020-2025, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2025, by Application, in Volume

7 REGION OPERATION

7.1 Regional Production
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2015-2019, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2015-2019, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2015-2019, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Upstream Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2025, by Application, in USD Million
Table Major Company List of Liraglutide
Table Major Company List of Lixisenatide
Table Major Company List of Albiglutide
Table Major Company List of Dulaglutide
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Type, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Type, in Volume
Table Novo Nordisk Overview List
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lily Overview List
Table Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amylin Overview List
Table Business Operation of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue 2015-2019, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume 2015-2019, by Company, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2025, by Application, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2025, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2020-2025, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2025, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2015-2019, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2015-2019, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2015-2019, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2015-2019, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2015-2019, by Region, in Volume
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2015-2019, by Country, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

LIST OF FIGURES

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Structure
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2015-2019, by Type, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2015-2019, by Type, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share in 2019, by Company, in Volume
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Market Concentration, in 2019
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists MMarket Concentration, in 2019
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2019
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2015-2019, in Volume
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2015-2019, in Volume
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2015-2019, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2015-2019, in Volume
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2020-2025, by Application, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2025, by Application, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview


More Publications